Skip to main content
. 2001 Jul 20;69(3):493–503. doi: 10.1086/321972

Table 1.

LOH and Clonality Analyses of TSC Lesions[Note]

Allele Status at
Patient (Sex) Inheritance Germline Mutation TumorType D16S663 D16S665 Kg8 Exon 40 TSC2GLM D16S525 D9S2126 D9S1830 TSC1GLM D9S1199 D9S1198 Clonality
1 (F) Sporadic TSC1, exon 15 (1711delTG,V497fs→503X) UF NI NI H H NA NI H H H H NI NI
2 (F) Sporadic TSC1, exon 15 (2148C→T, Q655X) AML H NI H NI NA NI NI H LOHa LOH LOH C
3 (M) Sporadic TSC1, exon 15 (2104T→A, L628X) SEGA H NI NI NI NA NI H H Ha H H NA
4 (F) Familial TSC2, intron 1, splice donor (138+1G→A) SEGA H H NI LOH LOHa LOH NI H NA NI H NT
5 (F) Sporadic TSC2, exon 30, 3685–3700del (Q1229fs→1296X) Rhabdo NI H NI NI H NI H NI NA NI H NI
6 (M) Sporadic TSC2, exon 12 (1348G→T, E450X) Rhabdo H NI NI NI Ha NI NI H NA H H NA
7 (F) Sporadic TSC2, exon 36 (4743delC, L1581fs→158Xb) AML H H H NI NAc LOH H H NA H H C
8 (F) Familial TSC2, exon 19 (2109G→A, W703X) LAM 1 H H H NI Ha NI H NI NA H H P
LAM 2 H H H NI Ha NI H NI NA H H P
LAM 3 H H H NI Ha NI H NI NA H H P
9 (F) Sporadic TSC2, exon 33 (4207delG, D1400fs→1410X) AML 1 NI LOH LOH NI LOH NI NI H NA H NI C
AML 2 NI H H NI H NI NI H NA H NI P
Tuber 1 NI H H NI H NI NI H NA H NI C
Tuber 2 NI H H NI H NI NI H NA H NI P
Tuber 3 NI H H NI H NI NI H NA H NI P
Tuber 4 NI H H NI H NI NI H NA H NI P
Tuber 5 NI H H NI H NI NI H NA H NI S
SEGA 1 NI H H NI H NI NI H NA H NI S
SEGA 2 NI H H NI H NI NI H NA H NI P
UF NI H H NI H NI NI H NA H NI C
GP NI H H NI H NI NI H NA H NI P
10 (F) Sporadic Not detected AML 1 LOH LOH NI NI NA LOH H H NA NI H P
AML 2 LOH LOH NI NI NA LOH H H NA NI H C
AML 3 LOH LOH NI NI NA LOH H H NA NI H P

Note.— Rhabdo = cardiac rhabdomyoma; GP = gastric polyp; GLM = germline mutation point; NI = not informative; H = heterozygous; NA = not applicable; NT = not tested owing to sample quantity; C = clonal; P = polyclonal; S = significantly skewed toward one allele.

a

Allelic status at the GLM was assessed by SSCP/sequencing, and only definite losses were scored as LOH; the remaining cases are scored as H, since allelic loss can be ambiguous if determined by SSCP or sequencing analysis.

b

Somatic mosaicism.

c

Owing to mosaicism.

HHS Vulnerability Disclosure